Name | Role | Date | Shares | Price | Value |
---|---|---|---|---|---|
James Kihara | PRINCIPAL ACCOUNTING OFFICER | 2025-04-08 | 1,028 | $14.82 | $15.23kSell |
Mark C. Schneyer | EVP CHIEF FINANCIAL OFFICER | 2025-04-08 | 2,708 | $14.82 | $40.13kSell |
Mark C. Schneyer | EVP CHIEF FINANCIAL OFFICER | 2025-03-26 | 3,171 | $17.05 | $54.07kSell |
James Kihara | PRINCIPAL ACCOUNTING OFFICER | 2025-03-26 | 1,095 | $17.05 | $18.67kSell |
Elizabeth A. Garofalo | Director | 2025-03-05 | 4,919 | $18.23 | $89.67kSell |
James Kihara | PRINCIPAL ACCOUNTING OFFICER | 2025-02-24 | 475 | $19.96 | $9.48kSell |
Mark C. Schneyer | EVP CHIEF FINANCIAL OFFICER | 2025-02-24 | 773 | $19.96 | $15.43kSell |
James Kihara | PRINCIPAL ACCOUNTING OFFICER | 2024-11-19 | 4,073 | $16.81 | $68.47kSell |
Mark C. Schneyer | EVP CHIEF FINANCIAL OFFICER | 2024-11-19 | 10,259 | $16.81 | $172.45kSell |
Brendan Teehan | EVP COO HEAD OF COMMERCIAL | 2024-11-19 | 10,329 | $16.81 | $173.63kSell |
Name | Hold | Shares | Value | Type |
---|---|---|---|---|
Baker Bros Advisors LP | 25.71% | 42,877,916 | $626.88M | Institution |
Baker Bros Advisors LP | 23.65% | 39,452,627 | $576.80M | Insider |
Baker Brothers Life Sciences LP | 8.53% | 14,229,612 | $208.04M | Insider |
Vanguard Group Inc | 8.36% | 13,947,640 | $203.91M | Institution |
Blackrock Inc | 7.63% | 12,729,859 | $186.11M | Institution |
Rtw Investments LP | 5.22% | 8,705,501 | $127.27M | Institution |
Morgan Stanley | 4.38% | 7,297,049 | $106.68M | Institution |
State Street Corp | 2.71% | 4,521,385 | $66.10M | Institution |
D E Shaw Co Inc | 1.94% | 3,241,406 | $47.39M | Institution |
Oxford Bioscience Partners IV LP | 1.89% | 3,160,238 | $46.20M | Insider |